Join us for an online support group meeting hosted by Alexandra, one of our Europe Support Group Leaders! Anyone is welcome, no matter where you are located. If you are an individual diagnosed or a care partner for someone with ADEM, AFM, MOGAD, NMOSD, ON, or TM, we invite you to join us. Connect with others and discuss what it’s like living with a rare neuroimmune disorder. Ask questions, share your stories, or just listen – everyone is welcome.
This month, the topic is focused on Expectations and Relationships, including relationships with partners, spouses, care partners or caregivers, friends, or others. This meeting will take place at 5pm Central European Time / 12pm Eastern Time / 9am Pacific Time. If you have any questions, please contact Alexandra at [email protected].
SRNA 2024 education and support programs are supported by donations from our community and in part through grants from
Amgen Rare Disease is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. They apply scientific expertise and courage to bring clinically meaningful therapies to patients. Amgen Rare Disease believes science and compassion must work together to transform lives.
Alexion is a global biopharmaceutical company focused on serving patients with severe and rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Their goal is to deliver medical breakthroughs where none currently exist, and they are committed to ensuring that patient perspective and community engagement is always at the forefront of their work.
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit https://www.gene.com.
* All educational content and programs are solely developed by the SRNA staff, members of the scientific board and approved by Board of Directors.
